Tomasz Pertyński
About
In The Last Decade
Tomasz Pertyński
78 papers receiving 518 citations
Peers
Comparison fields: 5 of 100
- Molecular Biology 174
- Endocrinology, Diabetes and Metabolism 131
- Genetics 118
- Cancer Research 78
- Oncology 74
Countries citing papers authored by Tomasz Pertyński
This map shows the geographic impact of Tomasz Pertyński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomasz Pertyński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomasz Pertyński more than expected).
Fields of papers citing papers by Tomasz Pertyński
This network shows the impact of papers produced by Tomasz Pertyński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomasz Pertyński. The network helps show where Tomasz Pertyński may publish in the future.
Co-authorship network of co-authors of Tomasz Pertyński
This figure shows the co-authorship network connecting the top 25 collaborators of Tomasz Pertyński. A scholar is included among the top collaborators of Tomasz Pertyński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomasz Pertyński. Tomasz Pertyński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Effect of transdermal hormone therapy on platelet haemostasis in menopausal women | 0 |
| 2 | Cukrzyca u kobiet menopauzalnych | 1 |
| 3 | Nowe aspekty leczenia osteoporozy pomenopauzalnej | 1 |
| 4 | Kliniczne aspekty atrofii urogenitalnej u kobiet | 2 |
| 5 | The single nucleotide polymorphism (SNP) in DNA repair genes by homologous recombination (XRCC2 and RAD51) and the risk of sporadic breast cancer in Poland | 1 |
| 6 | Izoflawony jako alternatywa dla terapii hormonalnej wieku menopauzalnego | 3 |
| 7 | Abnormal bleeding in the perimenopausal period | 1 |
| 8 | MDM2 gene polymorphism and endometrial cancer risk | 1 |
| 9 | Metabolic syndrome in women in the menopausal period | 5 |
| 10 | Stanowisko zespołu ekspertów Polskiego Towarzystwa Ginekologicznego, Polskiego Towarzystwa Kardiologicznego oraz Polskiego Towarzystwa Menopauzy i Andropauzy na temat wpływu terapii hormonalnej okresu menopauzalnego na układ sercowo-naczyniowy | 1 |
| 11 | Controversies on antioxidative effects of estrogens | 1 |
| 12 | Cardiovascular diseases in women – impact of the menopausal period | 2 |
| 13 | Hysteroscopy use in modern diagnostics and therapy | 1 |
| 14 | Breast cancer versus hormone therapy of the menopausal period | 1 |
| 15 | Genetic polymorphisms in coagulation and fibrinolysis systems versus thromboembolic risk of estrogen-progestin therapies in women | 1 |
| 16 | Evaluation of micronized progesterone influence on breast density | 1 |
| 17 | The risk of thromboembolic complications due to oral contraception and hormone replacement therapy | 1 |
| 18 | Osteoporosis – diagnostics and treatment | 1 |
| 19 | Komentarz redaktorów naczelnych Ginekologii po Dyplomie i Przeglądu Menopauzalnego Analiza wyników pracy: Risk and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women’s Health Initiative randomized controlled trial (WHI) | 7 |
| 20 | [Studies on the incidence and clinical significance of the metabolic syndrome in postmenopausal women in Lodz region]. | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.